Skip to main content
Equibles
DGX logo

DGX · Quest Diagnostics Inc · Analyst Estimates

Track DGX — free

Use DGX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DGX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$254.74 -0.94 (-0.37%) At close · Nov 5 Play latest call Q3 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$28.13B
Shares
110.02M
Volume · Nov 5 969.56K Avg daily vol (3M) 1M

Analyst Estimates

Compare analyst forecasts for Quest Diagnostics Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-06 03:57 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
11.25
11.32
11.43
15
11.20
11.19
11.19
11.19
0
1
13
14
Revenue
USD
Publication date not stated
12.06B
12.08B
12.10B
15
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
11.63
11.98
12.67
16
12.04
12.06
12.06
12.03
8
8
6
3
Revenue
USD
Publication date not stated
12.49B
12.62B
12.86B
15
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
2.63
2.68
2.74
13
2.68
2.68
2.68
2.68
3
3
5
5
Revenue
USD
Publication date not stated
3.03B
3.05B
3.07B
11
 — — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
2.59
2.70
2.84
10
2.76
2.77
2.77
2.76
7
6
1
0
Revenue
USD
Publication date not stated
3.00B
3.03B
3.08B
7
 — — — — — — — —
Key facts CIK 1022079 CUSIP 74834L100 13F (30d) 604 filings 555 filers Visit website Investor relations